AssessmeNT of the Incidence of Clostridium difficile Infections in hospitalized Patients on Antibiotic TrEatment - ANTICIPATE

niversitair Medisch Centrum Utrecht0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•1. Male or female hospitalized patient.
•2. Aged ><= 50 years old.
•3. Initiation of intravenous or oral treatment with intended duration *5 days (*1 day for clindamycin) with at least one of the following antibiotic classes, or treatment scheduled within the next 72 hours:
•- Third or fourth generation cephalosporins
•- Fluoroquinolones
•- Penicillins +beta-lactamase inhibitors
•- Clindamycin
•- Carbapenems
•4. Written informed consent provided prior to inclusion.

•1. Ongoing antibiotic treatment with one of the above classes initiated >6 hours before inclusion into the study.
•2. ICU admission at the time of inclusion or anticipated admission within 48h.
•3. Suspected or diagnosed CDI, ongoing treatment for CDI, or diarrhoea at the time of inclusion.
•4. Subject has been included into this study previously.
•5. Patient treated with probiotics to prevent CDI.
•6. Patient with any social or logistical condition which in the opinion of the investigator may interfere with the conduct of the study, such as incapacity to well understand, not willing to collaborate, or cannot easily be contacted after discharge.
•7. Subject deprived of liberty by judicial or administrative decision.

发起方

niversitair Medisch Centrum Utrecht